Primary prevention for HIT focuses on avoidance of heparin or heparin products. If there is no exposure to heparin, HIT cannot develop. For patients who much receive heparin, the use of low molecular weight heparin is preferred over unfractionated heparin with regards to prevention of HIT.
Heparin-induced thrombocytopenia primary prevention
Heparin-induced thrombocytopenia future or investigational therapies
Glanzmann's thrombasthenia medical therapy
Heparin-induced thrombocytopenia medical therapy
Thrombotic thrombocytopenic purpura secondary prevention
Antiphospholipid syndrome primary prevention
Antiphospholipid syndrome secondary prevention
Glanzmann's thrombasthenia future or investigational therapies